Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Protein-protein Interfaces

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...

Trial and Error and Algorithm

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Development and Dissemination of the Japanese Translation of the Mammalian Phenotype Ontology as an Open Resource.

Congenital anomalies·2026

Same author

Ontology-based expansion of virtual gene panels to improve diagnostic efficiency for rare genetic diseases.

BMC medical informatics and decision making·2025

Same author

Examining HPO by organ and system to facilitate practical use by clinicians.

Genomics & informatics·2024

Same author

BioHackathon 2015: Semantics of data for life sciences and reproducible research.

F1000Research·2020

Same author

Split4Blank: Maintaining consistency while improving efficiency of loading RDF data with blank nodes.

PloS one·2019

Same author

Erratum to: Suppression of c-Myc induces apoptosis via an AMPK/mTOR-dependent pathway by 4-O-methyl-ascochlorin in leukemia cells.

Apoptosis : an international journal on programmed cell death·2016

Search research articles

Related Experiment Video

Updated: Oct 4, 2025

Cloud-Based Phrase Mining and Analysis of User-Defined Phrase-Category Association in Biomedical Publications

Cloud-Based Phrase Mining and Analysis of User-Defined Phrase-Category Association in Biomedical Publications

Published on: February 23, 2019

Advances in the development of PubCaseFinder, including the new application programming interface and matching

Toyofumi Fujiwara¹, Jae-Moon Shin¹, Atsuko Yamaguchi²

¹Database Center for Life Science, Joint Support-Center for Data Science Research, Research Organization of Information and Systems, Kashiwa-shi, Chiba-ken, Japan.

|February 10, 2022

Summary

This summary is machine-generated.

PubCaseFinder, a rare disease diagnostic tool, has been updated with an improved algorithm and API. This enhances its ability to assist clinicians and patient repositories in diagnosing genetic diseases using Human Phenotype Ontology (HPO) data.

Keywords:

API HPO Matchmaker Exchange PubCaseFinder matching algorithm

More Related Videos

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Oct 4, 2025

Cloud-Based Phrase Mining and Analysis of User-Defined Phrase-Category Association in Biomedical Publications

Cloud-Based Phrase Mining and Analysis of User-Defined Phrase-Category Association in Biomedical Publications

Published on: February 23, 2019

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

Area of Science:

Medical Informatics
Genetics
Computational Biology

Background:

Over 10,000 rare genetic diseases are known, affecting millions of newborns annually.
Human Phenotype Ontology (HPO)-based clinical decision support systems (CDSS) aid in diagnosing rare genetic diseases.
PubCaseFinder, a web-based CDSS, was released in 2017 for HPO-based differential diagnosis.

Purpose of the Study:

To describe updates to the PubCaseFinder CDSS, its GeneYenta matching algorithm, and its Matchmaker Exchange (MME) API.
To enhance the automated differential diagnosis capabilities for rare genetic diseases.
To facilitate the use of HPO-based resources by medical professionals and patient repositories.

Main Methods:

Updated the GeneYenta matching algorithm within PubCaseFinder.
Enhanced the PubCaseFinder web application and its MME API.
Evaluated the improved performance of the CDSS differential diagnosis function.

Main Results:

The updated GeneYenta algorithm significantly improved PubCaseFinder's differential diagnosis performance.
The enhanced PubCaseFinder and new API streamline data querying for MME participants.
Increased accessibility and usability of HPO-based diagnostic tools for clinical use.

Conclusions:

The updated PubCaseFinder and GeneYenta algorithm provide a more powerful tool for diagnosing rare genetic diseases.
The enhanced MME API integration supports broader adoption and utilization of HPO data.
These advancements empower medical professionals and patient repositories in rare disease diagnosis.